JP2019194212A5 - - Google Patents

Download PDF

Info

Publication number
JP2019194212A5
JP2019194212A5 JP2019112469A JP2019112469A JP2019194212A5 JP 2019194212 A5 JP2019194212 A5 JP 2019194212A5 JP 2019112469 A JP2019112469 A JP 2019112469A JP 2019112469 A JP2019112469 A JP 2019112469A JP 2019194212 A5 JP2019194212 A5 JP 2019194212A5
Authority
JP
Japan
Prior art keywords
ferric
kidney disease
ferric citrate
chronic kidney
organic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019112469A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019194212A (ja
Filing date
Publication date
Priority claimed from PCT/US2006/032385 external-priority patent/WO2007022435A2/en
Application filed filed Critical
Publication of JP2019194212A publication Critical patent/JP2019194212A/ja
Publication of JP2019194212A5 publication Critical patent/JP2019194212A5/ja
Priority to JP2021159648A priority Critical patent/JP2022020633A/ja
Pending legal-status Critical Current

Links

JP2019112469A 2006-01-30 2019-06-18 慢性腎疾患の治療法 Pending JP2019194212A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021159648A JP2022020633A (ja) 2006-01-30 2021-09-29 慢性腎疾患の治療法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US76325306P 2006-01-30 2006-01-30
US60/763,253 2006-01-30
PCT/US2006/032385 WO2007022435A2 (en) 2005-08-18 2006-08-18 Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
USPCT/US2006/032385 2006-08-18

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015180311A Division JP6632842B2 (ja) 2006-01-30 2015-09-14 慢性腎疾患の治療法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021159648A Division JP2022020633A (ja) 2006-01-30 2021-09-29 慢性腎疾患の治療法

Publications (2)

Publication Number Publication Date
JP2019194212A JP2019194212A (ja) 2019-11-07
JP2019194212A5 true JP2019194212A5 (enExample) 2020-02-06

Family

ID=39739742

Family Applications (14)

Application Number Title Priority Date Filing Date
JP2008552431A Pending JP2009525276A (ja) 2006-01-30 2007-01-26 慢性腎疾患の治療法
JP2008552435A Pending JP2009525277A (ja) 2006-01-30 2007-01-26 軟組織石灰化の回復、予防、遅延または安定化方法
JP2013142517A Pending JP2013227333A (ja) 2006-01-30 2013-07-08 慢性腎疾患の治療法
JP2013142389A Active JP6154226B2 (ja) 2006-01-30 2013-07-08 軟組織石灰化の回復、予防、遅延または安定化方法
JP2014157464A Active JP6368186B2 (ja) 2006-01-30 2014-08-01 慢性腎疾患の治療法
JP2015180311A Active JP6632842B2 (ja) 2006-01-30 2015-09-14 慢性腎疾患の治療法
JP2016176150A Pending JP2017036289A (ja) 2006-01-30 2016-09-09 慢性腎疾患の治療法
JP2016252260A Pending JP2017095477A (ja) 2006-01-30 2016-12-27 慢性腎疾患の治療法
JP2017041248A Active JP6239169B2 (ja) 2006-01-30 2017-03-06 軟組織石灰化の回復、予防、遅延または安定化方法
JP2018006046A Pending JP2018109001A (ja) 2006-01-30 2018-01-18 慢性腎疾患の治療法
JP2019112469A Pending JP2019194212A (ja) 2006-01-30 2019-06-18 慢性腎疾患の治療法
JP2021159648A Pending JP2022020633A (ja) 2006-01-30 2021-09-29 慢性腎疾患の治療法
JP2023015069A Pending JP2023055886A (ja) 2006-01-30 2023-02-03 慢性腎疾患の治療法
JP2024168044A Pending JP2025016448A (ja) 2006-01-30 2024-09-27 慢性腎疾患の治療法

Family Applications Before (10)

Application Number Title Priority Date Filing Date
JP2008552431A Pending JP2009525276A (ja) 2006-01-30 2007-01-26 慢性腎疾患の治療法
JP2008552435A Pending JP2009525277A (ja) 2006-01-30 2007-01-26 軟組織石灰化の回復、予防、遅延または安定化方法
JP2013142517A Pending JP2013227333A (ja) 2006-01-30 2013-07-08 慢性腎疾患の治療法
JP2013142389A Active JP6154226B2 (ja) 2006-01-30 2013-07-08 軟組織石灰化の回復、予防、遅延または安定化方法
JP2014157464A Active JP6368186B2 (ja) 2006-01-30 2014-08-01 慢性腎疾患の治療法
JP2015180311A Active JP6632842B2 (ja) 2006-01-30 2015-09-14 慢性腎疾患の治療法
JP2016176150A Pending JP2017036289A (ja) 2006-01-30 2016-09-09 慢性腎疾患の治療法
JP2016252260A Pending JP2017095477A (ja) 2006-01-30 2016-12-27 慢性腎疾患の治療法
JP2017041248A Active JP6239169B2 (ja) 2006-01-30 2017-03-06 軟組織石灰化の回復、予防、遅延または安定化方法
JP2018006046A Pending JP2018109001A (ja) 2006-01-30 2018-01-18 慢性腎疾患の治療法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021159648A Pending JP2022020633A (ja) 2006-01-30 2021-09-29 慢性腎疾患の治療法
JP2023015069A Pending JP2023055886A (ja) 2006-01-30 2023-02-03 慢性腎疾患の治療法
JP2024168044A Pending JP2025016448A (ja) 2006-01-30 2024-09-27 慢性腎疾患の治療法

Country Status (11)

Country Link
US (8) US20090186939A1 (enExample)
EP (3) EP1978808B1 (enExample)
JP (14) JP2009525276A (enExample)
CN (4) CN105055446B (enExample)
AU (2) AU2007210090B2 (enExample)
CA (2) CA2640974C (enExample)
DK (1) DK1978807T3 (enExample)
ES (2) ES2580127T3 (enExample)
HU (1) HUE028029T2 (enExample)
IL (2) IL192545A (enExample)
WO (2) WO2007089577A2 (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220144872A1 (en) * 2003-02-19 2022-05-12 Panion & Bf Biotech Inc. Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
CN105055446B (zh) * 2006-01-30 2022-06-03 宝龄富锦生技股份有限公司 逆转、防止、延迟或稳定软组织钙化的方法
US7658952B2 (en) 2007-10-11 2010-02-09 Baxter International Inc. Dialysis solutions containing pyrophosphates
CN102164596A (zh) 2008-10-27 2011-08-24 Sbi5-Ala生物技术股份有限公司 以5-氨基乙酰丙酸或其衍生物、或它们的盐作为有效成分的成人病的预防、改善剂
KR20140016438A (ko) 2009-07-21 2014-02-07 케릭스 바이오파마슈티컬스 인코포레이티드 구연산철 투여형태
US8178709B2 (en) * 2009-07-21 2012-05-15 Biolink Life Sciences, Inc. Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof
EP2594277A4 (en) * 2010-07-07 2014-01-01 Japan Tobacco Inc TABLET WITH IRON CITRATE
JP2012112785A (ja) * 2010-11-24 2012-06-14 Tohoku Univ 透析膜の評価方法
WO2012099139A1 (ja) * 2011-01-18 2012-07-26 日本たばこ産業株式会社 β酸化水酸化鉄を実質的に含まないクエン酸第二鉄
PL3730136T3 (pl) * 2012-06-21 2024-03-25 Keryx Biopharmaceuticals, Inc. Zastosowanie cytrynianu żelaza(iii) w leczeniu pacjentów z przewlekłą chorobą nerek
JP6348495B2 (ja) * 2012-09-04 2018-06-27 ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム シトレートに富むカルシウム・マグネシウム補助剤およびその使用
AU2014341975A1 (en) * 2013-11-04 2016-05-19 Keryx Biopharmaceuticals, Inc. Ferric citrate for reducing cardiac failure in chronic kidney disease patients
US10172882B2 (en) 2014-06-22 2019-01-08 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
US20180222836A1 (en) * 2015-08-05 2018-08-09 Lupin Limited Process for the Preparation of Pharmaceutical Grade Ferric Citrate
WO2018193648A1 (ja) * 2017-04-18 2018-10-25 国立大学法人東北大学 アルカリ性化剤による血液浄化
JP7578234B2 (ja) * 2017-04-18 2024-11-06 国立大学法人東北大学 アルカリ性化剤による血液浄化
JP7219898B2 (ja) * 2017-04-18 2023-02-09 国立大学法人東北大学 アルカリ性化剤による血液浄化
IT201700085412A1 (it) * 2017-07-26 2019-01-26 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT201700089258A1 (it) 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
KR102825650B1 (ko) 2018-01-12 2025-06-26 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 체액 중의 암모니아 및 암모늄의 검출 및 정량화를 위한 시스템 및 방법
US20210267959A1 (en) * 2018-07-17 2021-09-02 The Regents Of The University Of California Methods of treating renal disease
EP3868371A4 (en) 2018-10-17 2022-11-02 Tohoku University Novel pharmaceutical composition
KR20210076008A (ko) * 2018-10-17 2021-06-23 교토후고리츠다이가쿠호진 당뇨병 신증에 있어서의 신장 섬유화 억제제
CA3137691A1 (en) * 2019-04-28 2020-11-05 Tohoku University Novel pharmaceutical composition
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
JP2024507417A (ja) * 2021-02-24 2024-02-19 モクシーテック リミテッド ライアビリティ カンパニー イヌパルボウイルス感染を治療するための組成物および方法
CN117999069A (zh) 2021-05-27 2024-05-07 凯克斯生物制药公司 柠檬酸铁的儿科调配物
KR102623739B1 (ko) * 2022-07-28 2024-01-11 주식회사 페라메드 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2081547A (en) 1934-02-14 1937-05-25 Parke Davis & Co Therapeutic agent
DE1131360B (de) 1957-11-26 1962-06-14 Vitarine Company Inc Verfahren zum Stabilisieren von waessrigen Loesungen, die neben Vitamin B noch Vitamin B und Vitamin C enthalten
SU142643A1 (ru) 1961-03-25 1961-11-30 В.Б. Тихомиров Способ извлечени соединений железа из водной фазы
AT279048B (de) * 1967-07-04 1970-02-25 Pharmazeutische Fabrik Montavit Gmbh Verfahren zur Herstellung neuer, löslicher und stabiler organischer Eisen(III)-Komplexverbindungen und Injektionslösungen davon
US3549614A (en) 1967-07-13 1970-12-22 Jan Zbigniew Mioduszewski Method of manufacture of mixed complex compounds of ferric iron with hydrogenated dextran and citric acid or sodium citrate
GB1224589A (en) 1969-10-06 1971-03-10 Gerhard Gergely Complex iron salts
US4180567A (en) * 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same
DE3228231A1 (de) 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
US5089644A (en) 1985-01-04 1992-02-18 Salutar Inc. Preparation of oxamine complexes
US4851221A (en) 1985-02-19 1989-07-25 Mission Pharmacal Company Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid
IT1222654B (it) 1987-09-14 1990-09-12 Schering Ag Complesso micellare di ferro-citrato
GB2212396A (en) 1987-12-18 1989-07-26 Procter & Gamble Dietary supplement comprising calcium and delayed release coated iron
US5602116A (en) * 1988-08-02 1997-02-11 Bone Care International, Inc. Method for treating and preventing secondary hyperparathyroidism
NL194959C (nl) 1988-10-04 2003-09-02 Otsuka Pharma Co Ltd Preparaat voor het toedienen van ijzer.
WO1990009102A1 (en) * 1989-02-17 1990-08-23 Baxter International Inc. Calcification mitigation of bioprosthetic implants
US4970079A (en) * 1989-06-05 1990-11-13 Purdue Research Foundation Method and composition of oxy-iron compounds for treatment of hyperphosphatemia
JP2523057B2 (ja) 1990-10-31 1996-08-07 有限会社丸吉商事 多重ポリ袋の製造方法及び製造装置
DE4239442C2 (de) 1992-11-24 2001-09-13 Sebo Gmbh Verwendung eines mit polynuklearen Metalloxidhydroxiden modifizierten Adsorptionsmaterials zur selektiven Elimination von anorganischem Phosphat aus proteinhaltigen Flüssigkeiten
JP3302178B2 (ja) 1994-06-22 2002-07-15 日本クラウンコルク株式会社 合成樹脂製容器蓋
JPH08198760A (ja) 1995-01-20 1996-08-06 Japan Organo Co Ltd 経口用リン酸イオン吸着剤
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
DE19638044A1 (de) 1996-09-18 1998-03-19 Bayer Ag Immunogene Peptide von Maul- und Klauenseuchen-Viren
US5753706A (en) 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
RU2188033C2 (ru) 1997-03-18 2002-08-27 Рош Диагностикс Гмбх Комбинированные фармацевтические препараты, содержащие эритропоэтин и препараты железа
US6254635B1 (en) * 1998-02-02 2001-07-03 St. Jude Medical, Inc. Calcification-resistant medical articles
US6706287B2 (en) * 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
CN1315174A (zh) 2000-03-31 2001-10-03 苏荣仁 治疗肾衰的药物组合物
US6887897B2 (en) * 2001-07-31 2005-05-03 Mission Pharmacal Company Calcium glutarate supplement and phosphorus binder
KR101011373B1 (ko) 2002-07-11 2011-01-28 비큐론 파마슈티컬스 인코포레이티드 항균작용을 갖는 n-히드록시아미드 유도체
CN1202067C (zh) * 2002-09-09 2005-05-18 苏荣仁 药用级枸橼酸铁的制备方法
US8093423B2 (en) * 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
KR100511227B1 (ko) 2003-06-27 2005-08-31 박상래 휴대용 감시 카메라 및 이를 이용한 개인 방범 시스템
TWI259772B (en) 2003-09-04 2006-08-11 Panion & Bf Biotech Inc Medical composition comprising ferric citrate, ferric citrate in medical grade and preparation thereof, and dietary nutriment comprising ferric citrate
CN1600302A (zh) 2003-09-22 2005-03-30 宝龄富锦生技股份有限公司 含有柠檬酸铁的医药组合物以及药用级柠檬酸铁及其制法和含有药用级柠檬酸铁的膳食营养品
US6903235B2 (en) 2003-10-08 2005-06-07 Panion & Bf Biotech Inc. Pharmaceutical-grade ferric citrate
BRPI0513603A (pt) * 2004-07-27 2008-05-13 Shire Pharmaceuticals Inc uso de hidroxicarbonato de lantánio e composição farmacêutica
US7733285B2 (en) * 2005-05-18 2010-06-08 Qualcomm Incorporated Integrated, closely spaced, high isolation, printed dipoles
US7904971B2 (en) * 2005-05-19 2011-03-15 Mine Safety Appliances Company Protective padding and protective padding systems
KR20080037083A (ko) 2005-08-18 2008-04-29 글로보아시아 엘엘씨 약학용 등급의 유기 철 화합물, 그 용도 및 이의 제조 방법
JP4692234B2 (ja) 2005-11-10 2011-06-01 ソニー株式会社 変調テーブル、変調装置および方法、プログラム、並びに記録媒体
US7682811B2 (en) 2006-01-27 2010-03-23 University Of Massachusetts Systems and methods for producing biofuels and related materials
CN105055446B (zh) 2006-01-30 2022-06-03 宝龄富锦生技股份有限公司 逆转、防止、延迟或稳定软组织钙化的方法
KR20080106506A (ko) 2006-01-30 2008-12-08 글로보아시아 엘엘씨 만성 신장병의 치료 방법
CN101019848B (zh) 2006-11-17 2010-09-15 苏荣仁 枸橼酸铁在制备防治血管钙化的药物中的应用
CN101682017B (zh) 2007-05-31 2012-10-10 株式会社Lg化学 组装型电连接构件及包含该电连接构件的二次电池组
JP5526466B2 (ja) 2007-07-17 2014-06-18 株式会社大林組 耐火セグメントの製造方法
CN101235186B (zh) 2008-01-03 2010-08-11 中国船舶重工集团公司第七二五研究所 一种无溶剂可自分层固化的环氧-有机硅组合物
KR20140016438A (ko) 2009-07-21 2014-02-07 케릭스 바이오파마슈티컬스 인코포레이티드 구연산철 투여형태

Similar Documents

Publication Publication Date Title
JP2019194212A5 (enExample)
JP2015212268A5 (enExample)
JP2013536195A5 (enExample)
JP2009533356A5 (enExample)
JP2013501224A5 (enExample)
ES2971959T3 (es) Terlipresina para el tratamiento de la ascitis debida a cirrosis hepática administrada como una infusión continua
JP2016510326A5 (enExample)
JP2006503109A5 (enExample)
JPH01226810A (ja) 悪性腫瘍を破壊する作用を有する剤、その製造方法及び癌疾患の治療に使用する調製物
JP2001520656A (ja) 抗腫瘍剤としてのホルボールエステル類
KR102252944B1 (ko) 투석 조성물
JP2017514858A5 (enExample)
EP2799074A1 (en) Iron bis-glycinate chelate for use in the oral treatment of anemia in patients with celiac disease
CN104402706A (zh) 一种高纯度枸橼酸钙的制备方法
JP2018529674A5 (enExample)
JP2016514142A5 (enExample)
CN107106602B (zh) 肝纤维化改善剂
WO2013143462A1 (zh) 一种血液置换基础液及其制备方法
Wei et al. Appropriate treatment of acute sigmoid volvulus in the emergency setting
CN109106724A (zh) 一种苹果酸碳酸氢盐体外血液透析剂
CA2638081A1 (en) Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions
Bae et al. S-86 Case of Primary Aortoenteric Fistula to Proximal Rectum
Yamada Aspirin/heparin
Rane Oxymorphone abuse
Kang et al. PS 0960; Successful Treatment of Duodenal Variceal Bleeding by Percutaneous Transsplenic Embolization